February 04, 2026
Teva Pharmaceuticals urged a New Jersey federal judge Wednesday to reject a class certification bid by a group of direct buyers of the antidepressant drug Effexor XR and its generic versions, arguing that the proposed class failed to carry its burden showing that joinder is impracticable.
March 18, 2025
A proposed class of indirect drug purchasers have asked a New Jersey federal judge for his initial sign-off on a $2.25 million deal with Teva Pharmaceuticals to resolve antitrust claims against the company over antidepressant and anxiety disorder treatment Effexor XR.
October 18, 2024
A class of consumers and third-party payers have reached a deal with Teva Pharmaceuticals to resolve antitrust litigation over a purported scheme to delay generic competition for the antidepressant drug Effexor XR, according to a court filing.
June 11, 2024
Ten law firms asked a New Jersey federal judge on Monday to award $13 million in counsel fees and an additional $2.1 million in costs for representing direct buyers in a $39 million settlement with Pfizer Inc. unit Wyeth over an alleged scheme to delay generic competition for the antidepressant drug Effexor XR.
April 29, 2024
A proposed class of indirect buyers have asked a New Jersey federal judge to greenlight a $25.5 million settlement to end allegations that Pfizer unit Wyeth engaged in a scheme with Teva Pharmaceuticals to delay generic competition for the antidepressant Effexor XR.
April 10, 2024
A proposed class of direct buyers asked a New Jersey federal judge on Tuesday to approve a $39 million settlement to end allegations that Pfizer Inc. unit Wyeth engaged in a scheme with Teva Pharmaceuticals to delay generic competition for the antidepressant drug Effexor XR.
January 16, 2015
Walgreen Co., Rite Aid Corp. and other drug buyers notified a New Jersey federal judge on Thursday that they would be appealing to the Third Circuit his decision to dismiss their claim against Wyeth Inc. and Teva Pharmaceuticals USA Inc. over a no-authorized-generic deal for antidepressant Effexor XR.
October 22, 2014
Drug buyers on Tuesday urged a New Jersey federal judge to allow them to amend their complaint against Wyeth Inc. and Teva Pharmaceuticals USA Inc. over a no-authorized-generic deal for antidepressant Effexor XR, saying the court's new pleading standard is novel and was only introduced after they filed their suit.
June 19, 2014
A class of direct purchasers accusing Wyeth LLC and Teva Pharmaceuticals USA Inc. of making an anti-competitive deal to delay a generic version of the antidepressant Effexor XR criticized Wyeth on Thursday for trying to use an old consent decree to bolster its immunity argument, claiming the decree was brought up too late.
May 01, 2014
Wyeth LLC told a New Jersey federal judge on Wednesday that U.S. Supreme Court precedent gave it immunity against antitrust claims from a class of drug wholesalers accusing it of making a deal with Teva Pharmaceuticals USA Inc. to delay a generic version of antidepressant Effexor XR.